CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $35,023,032
- in 1 filing
- Open-market sales, last 90 days
- $7,011,938
- in 3 filings, $6.7M under 10b5-1 plans
Net +$28,011,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-07-22 | CRAVES FRED B Director | Grant or award | +119,380 | 119,380 | ||
| 2016-07-22 | Schneebaum Marc R Chief Financial Officer | Grant or award | +22,969 | 42,277 | ||
| 2016-07-22 | Schneebaum Marc R Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +91,876 | 91,876 | ||
| 2016-07-22 | FRIEDMAN PAUL A Chief Executive Officer | Grant or award | +146 | 146 | ||
| 2016-07-22 | FRIEDMAN PAUL A Chief Executive Officer | Grant or award | +143,557 | 143,703 | ||
| 2016-07-22 | FRIEDMAN PAUL A Chief Executive Officer | Grant or award | +729,066 | 729,066 | ||
| 2016-07-22 | FRIEDMAN PAUL A Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +287,115 | 287,115 | ||
| 2016-07-22 | Taub Rebecca Chief Medical Officer, EVP R&D | Grant or award | +729,066 | 729,066 | ||
| 2016-07-22 | Taub Rebecca Chief Medical Officer, EVP R&D | Grant or award | +404,132 | 404,132 | ||
| 2016-07-22 | Taub Rebecca Chief Medical Officer, EVP R&D | Grant or award | +28,740 | 432,872 | ||
| 2016-07-22 | Taub Rebecca Chief Medical Officer, EVP R&D | Grant or award · Employee Stock Option (Right to Buy) | +143,557 | 143,557 | ||
| 2016-07-22 | Schor Chen Former President and CEO | Grant or award | +42,857 | 51,428 | ||
| 2016-07-22 | Schor Chen Former President and CEO | Shares withheld for taxes | −14,250 | $9.48 | $135K | 37,178 |
| 2016-07-22 | Schneebaum Marc R SVP and CFO | Grant or award | +25,714 | 27,856 | ||
| 2016-07-22 | Schneebaum Marc R SVP and CFO | Shares withheld for taxes | −8,548 | $9.48 | $81K | 19,308 |
| 2016-07-22 | Rieder Wendy E Former SVP, Gen. Counsel | Grant or award | +25,714 | 26,280 | ||
| 2016-07-22 | Rieder Wendy E Former SVP, Gen. Counsel | Shares withheld for taxes | −8,550 | $9.48 | $81K | 17,730 |
| 2016-01-01 | Morenstein Scott D Director | Grant or award | +17,857 | 17,857 | ||
| 2015-12-14 | Gollust Keith R Director | Sale | −300,000 | $0.32 | $97K | 1,539,169 |
| 2015-12-11 | Gollust Keith R Director | Sale | −300,000 | $0.37 | $111K | 1,839,169 |
Page 59 of 82 · 1,629 trades